Purchase Order 75F40123P00044
Award Date 2/15/23
Potential Completion Date 6/30/23
Potential Value $47K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Boston, MA 02110, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $22,000 purchase order to Haemonetics Corporation for a TEG Manager software license. Haemonetics, doing business as Haemonetics, will deliver the licensed software as the prime contractor. The firm fixed price contract has a period of performance starting August 7, 2023 through August 31, 2024 in Boston, Massachusetts. No set aside designation or subcontractors were indicated. The HHS FDA regulates...
- Haemonetics Corporation, headquartered in Boston, Massachusetts, was awarded a firm fixed-price purchase order by a civilian federal agency's Shared Services Center for portable blood analyzers, with a contract value of $131,896.12 and an ultimate completion date of July 1, 2026. The contract was awarded on a full and open competitive basis without set-aside restrictions. Performance will be executed at Haemonetics' Boston facility, leveraging the company's extensive expertise as a leading...
- This federal contract award is for the calibration of three TEG 5000 Analyzers. The contract was awarded by the Bureau of Medicine and Surgery, which is a defense agency, to the prime contractor Haemonetics Corporation. The contract has a firm fixed price of $4,785.91 and was awarded on June 13, 2017, with a completion date of August 9, 2018. The contract does not have a set-aside designation. Haemonetics Corporation is a leading provider of blood and plasma management products and services to...
- This is a firm-fixed price purchase order contract awarded by the Department of Defense (DoD) Medical Command (MEDCOM) to Haemonetics Corporation, a leading medical technology company, for the provision of a HEMOSTASIS ANALYZER. The contract has a ceiling value of $81,765.00 and an ultimate completion date of October 2, 2017. This contract does not have a set-aside designation, indicating Haemonetics competed effectively as a large, established medical technology corporation. Haemonetics also...
- Haemonetics Corporation has been awarded a firm fixed price purchase order contract valued at approximately $22,836 by the Department of Health and Human Services National Institutes of Health Clinical Center. This one-year maintenance agreement is needed by the Department of Laboratory Medicine to support TEG 5000 instruments and will be performed in Bethesda, Maryland. No set-aside designation was applied to this solicitation. Haemonetics Corporation will serve as the prime contractor to...
- This is a firm-fixed-price purchase order awarded by the Veterans Integrated Service Network 1 (VISN 1), a civilian agency within the U.S. Department of Veterans Affairs. The contract, valued at $12,222.00, is for the procurement of TEG6 PLATINUM SERVICE medical equipment and services from the prime contractor, Haemonetics Corporation, a leading medical technology company based in Boston, Massachusetts. The contract has no set-aside designation, indicating it was awarded on a full and open...
- The Defense Health Agency awarded a $39,282.35 firm fixed-price purchase order to Haemonetics Corporation for hemostasis supplies. The award, issued on August 8, 2025, with an ultimate completion date of August 8, 2025, represents a straightforward procurement with no set-aside designation, indicating open and competitive bidding. Performance will take place in Bethesda, Maryland. Haemonetics, a Boston-based medical technology leader, specializes in blood and plasma management products and is...
- The Defense Health Agency awarded a firm fixed-price purchase order to Haemonetics Corporation on October 1, 2024, for maintenance, repair, and rebuild services on medical equipment with a ceiling value of $69,732.00 and a completion date of September 30, 2027. The work will be performed at the contractor's facility in San Diego, California. This is a non-set-aside award reflecting Haemonetics' established position as a qualified supplier capable of competing in open federal procurement....
- <p>The Defense Health Agency awarded a purchase order to Haemonetics Corporation for $87,900 on February 12, 2026. The order covers arterial and venous closure sheaths for cardiac electrophysiology procedures, enabling same-day discharge and earlier patient ambulation. Performance occurs at Gaithersburg, Maryland. The purchase order is firm fixed-price with an ultimate completion date of February 12, 2026.</p>
- This firm-fixed price purchase order was awarded to Haemonetics Corporation, a leading medical technology company, by the Defense Health Agency. The contract is for the delivery of a 2600-110-US OMNI SEALER SYSTEM, a specialized medical device, with a ceiling value of $6,321.50. The contract has no set-aside designation, indicating Haemonetics competed effectively as a large, established corporation. The award is part of Haemonetics' broader federal contract portfolio, which includes providing...
The Food and Drug Administration awarded a purchase order to Haemonetics Corporation on February 15, 2023, for a Haemonetics TEG Hemostasis Analyzer, with a ceiling value of $46,895.00. No set-aside was used. Place of performance is Boston, Massachusetts. The order has a firm fixed-price structure and an ultimate completion date of June 30, 2023.
Generated 5/27/26, 10:51 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $46.9k | 2/14/23 |